» Articles » PMID: 26677014

Benign Infantile Seizures and Paroxysmal Dyskinesia Caused by an SCN8A Mutation

Abstract

Objective: Benign familial infantile seizures (BFIS), paroxysmal kinesigenic dyskinesia (PKD), and their combination-known as infantile convulsions and paroxysmal choreoathetosis (ICCA)-are related autosomal dominant diseases. PRRT2 (proline-rich transmembrane protein 2 gene) has been identified as the major gene in all 3 conditions, found to be mutated in 80 to 90% of familial and 30 to 35% of sporadic cases.

Methods: We searched for the genetic defect in PRRT2-negative, unrelated families with BFIS or ICCA using whole exome or targeted gene panel sequencing, and performed a detailed cliniconeurophysiological workup.

Results: In 3 families with a total of 16 affected members, we identified the same, cosegregating heterozygous missense mutation (c.4447G>A; p.E1483K) in SCN8A, encoding a voltage-gated sodium channel. A founder effect was excluded by linkage analysis. All individuals except 1 had normal cognitive and motor milestones, neuroimaging, and interictal neurological status. Fifteen affected members presented with afebrile focal or generalized tonic-clonic seizures during the first to second year of life; 5 of them experienced single unprovoked seizures later on. One patient had seizures only at school age. All patients stayed otherwise seizure-free, most without medication. Interictal electroencephalogram (EEG) was normal in all cases but 2. Five of 16 patients developed additional brief paroxysmal episodes in puberty, either dystonic/dyskinetic or "shivering" attacks, triggered by stretching, motor initiation, or emotional stimuli. In 1 case, we recorded typical PKD spells by video-EEG-polygraphy, documenting a cortical involvement.

Interpretation: Our study establishes SCN8A as a novel gene in which a recurrent mutation causes BFIS/ICCA, expanding the clinical-genetic spectrum of combined epileptic and dyskinetic syndromes.

Citing Articles

Transcriptomic analyses of human brains with Alzheimer's disease identified dysregulated epilepsy-causing genes.

Eteleeb A, Alves S, Buss S, Shafi M, Press D, Garcia-Cairasco N medRxiv. 2025; .

PMID: 39974070 PMC: 11838929. DOI: 10.1101/2025.01.02.25319900.


Sleep disturbances in SCN8A-related disorders.

Furia F, Johannesen K, Bonardi C, Previtali R, Aledo-Serrano A, Mastrangelo M Epilepsia Open. 2024; 9(6):2186-2197.

PMID: 39361253 PMC: 11633700. DOI: 10.1002/epi4.13042.


Channelopathies in epilepsy: an overview of clinical presentations, pathogenic mechanisms, and therapeutic insights.

Ng A, Chahine M, Scantlebury M, Appendino J J Neurol. 2024; 271(6):3063-3094.

PMID: 38607431 DOI: 10.1007/s00415-024-12352-x.


Identification of a de novo CACNA1B variant and a start-loss ADRA2B variant in paroxysmal kinesigenic dyskinesia.

Yuan Z, Wang Q, Wang C, Liu Y, Fan L, Liu Y Heliyon. 2024; 10(7):e28674.

PMID: 38571653 PMC: 10988053. DOI: 10.1016/j.heliyon.2024.e28674.


Genetic and phenotypic analyses of PRRT2 positive and negative paroxysmal kinesigenic dyskinesia.

Zhang Y, Ren J, Yang T, Xiong W, Qin L, An D Ther Adv Neurol Disord. 2024; 17:17562864231224110.

PMID: 38250317 PMC: 10798112. DOI: 10.1177/17562864231224110.